Most HPV-Linked Cancers Due to Types Targeted by 9vHPV Vaccine
In 2012 to 2016, an estimated 92% of cancers attributable to HPV were due to HPV types targeted by the 9vHPV vaccine.
Human Papillomavirus
Educational Intervention Improves HPV Vaccination
Educational interventions delivered in a clinical setting may improve vaccination behaviors.
Inaccurate Parental Reporting of HPV Vaccination Linked to Multilevel Sociodemographic Factors
Parents of racial or ethnic minority adolescents were more likely to inaccurately report HPV vaccination initiation.
Update on the Ethics of Mandating HPV Vaccination
Following diagnosis, 66.2% of women with the disease survive 5 or more years.1 HPV causes the majority of cervical cancer cases.
USPSTF Revisits Whether Annual Cervical Cancer Screening is Necessary
The US Preventive Services Task Force recommends cervical cancer screening with cervical cytology alone every 3 years or screening with high-risk human papillomavirus testing alone every 5 years.
More Teens Starting HPV Vaccine, Says CDC
While more teenagers are now starting the HPV vaccination dose cycle, many still aren’t completing the full series.
Anal Cancer Diagnosis Increases Risk of HPV-Linked Cancers
Men have higher standardized incidence ratio than women for second primary malignancy.
Nearly Half of Americans Younger Than 60 Years Old Infected with HPV
But the vaccine should turn the tide against the virus, researcher says.
AAP Suggests Adolescent Vaccination Rates Need Improvement
HPV and influenza immunization rates remain well below goals, says AAP.
Male Genital HPV Prevalence Rates High in United States
Although the HPV vaccine is recommended, too few are getting it, researchers say.
